BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9130285)

  • 1. Cognitive dysfunctions induced by scopolamine are reduced by systemic or intrahippocampal mineralocorticoid receptor blockade.
    Smythe JW; Murphy D; Timothy C; Gul GH; Costall B
    Pharmacol Biochem Behav; 1997 Apr; 56(4):613-21. PubMed ID: 9130285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine receptor stimulation blocks scopolamine-induced learning impairments in a water maze task.
    Smythe JW; Murphy D; Costall B
    Brain Res Bull; 1996; 41(5):299-304. PubMed ID: 8924041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats.
    Janas AM; Cunningham SC; Duffy KB; Devan BD; Greig NH; Holloway HW; Yu QS; Markowska AL; Ingram DK; Spangler EL
    Life Sci; 2005 Jan; 76(10):1073-81. PubMed ID: 15620572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat.
    Ogren SO; Kehr J; Schött PA
    Neuroscience; 1996 Dec; 75(4):1127-40. PubMed ID: 8938746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task.
    McIntyre CK; Ragozzino ME; Gold PE
    Behav Brain Res; 1998 Oct; 95(2):219-26. PubMed ID: 9806441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine.
    Jung WY; Kim H; Park HJ; Jeon SJ; Park HJ; Choi HJ; Kim NJ; Jang DS; Kim DH; Ryu JH
    J Ethnopharmacol; 2016 Aug; 190():165-73. PubMed ID: 27267831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test.
    Smythe JW; Bhatnagar S; Murphy D; Timothy C; Costall B
    Brain Res Bull; 1998; 45(1):89-93. PubMed ID: 9434207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraining intrahippocampal estradiol injections enhance spatial memory in male rats: interaction with cholinergic systems.
    Packard MG; Kohlmaier JR; Alexander GM
    Behav Neurosci; 1996 Jun; 110(3):626-32. PubMed ID: 8889009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition.
    Gibbs RB
    Horm Behav; 1999 Dec; 36(3):222-33. PubMed ID: 10603286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hebb-Williams performance and scopolamine challenge in rats with partial immunotoxic hippocampal cholinergic deafferentation.
    Marques Pereira P; Cosquer B; Schimchowitsch S; Cassel JC
    Brain Res Bull; 2005 Jan; 64(5):381-94. PubMed ID: 15607826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes.
    Maviel T; Durkin TP
    Neuroscience; 2003; 120(4):1049-59. PubMed ID: 12927210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists.
    Saber AJ; Cain DP
    Neuropsychopharmacology; 2003 Jul; 28(7):1247-56. PubMed ID: 12700678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
    Klinkenberg I; Blokland A
    Psychopharmacology (Berl); 2011 Jun; 215(3):549-66. PubMed ID: 21336581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of St-587 and prazosin on water maze and passive avoidance performance of scopolamine-treated rats.
    Puumala T; Sirviö J; Ruotsalainen S; Riekkinen P
    Pharmacol Biochem Behav; 1996 Sep; 55(1):107-15. PubMed ID: 8870045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus.
    Portero-Tresserra M; Del Olmo N; Martí-Nicolovius M; Guillazo-Blanch G; Vale-Martínez A
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1798-807. PubMed ID: 25453488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task.
    Orsetti M; Ghi P; Di Carlo G
    Behav Brain Res; 2001 Oct; 124(2):235-42. PubMed ID: 11640976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.
    Portero-Tresserra M; Cristóbal-Narváez P; Martí-Nicolovius M; Guillazo-Blanch G; Vale-Martínez A
    PLoS One; 2013; 8(8):e70584. PubMed ID: 23936452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
    Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
    Carli M; Bonalumi P; Samanin R
    Brain Res; 1997 Nov; 774(1-2):167-74. PubMed ID: 9452205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats.
    Yau JL; Noble J; Seckl JR
    Neurosci Lett; 1999 Dec; 277(1):45-8. PubMed ID: 10643894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.